| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/S00726-005-0289-3 |
| P698 | PubMed publication ID | 16622600 |
| P2093 | author name string | Bernkop-Schnürch A | |
| Werle M | |||
| P433 | issue | 4 | |
| P304 | page(s) | 351-367 | |
| P577 | publication date | 2006-04-20 | |
| P1433 | published in | Amino Acids | Q15757015 |
| P1476 | title | Strategies to improve plasma half life time of peptide and protein drugs | |
| P478 | volume | 30 |
| Q64993130 | A Comprehensive Review on Current Advances in Peptide Drug Development and Design. |
| Q41968812 | A Modular Method for the High-Yield Synthesis of Site-Specific Protein-Polymer Therapeutics |
| Q89164775 | A brush-polymer conjugate of exendin-4 reduces blood glucose for up to five days and eliminates poly(ethylene glycol) antigenicity |
| Q27700058 | A cactus-derived toxin-like cystine knot Peptide with selective antimicrobial activity |
| Q37595410 | A free cysteine prolongs the half-life of a homing peptide and improves its tumor-penetrating activity |
| Q57364535 | A glucose-responsive complex polymeric micelle enabling repeated on–off release and insulin protection |
| Q87367580 | A high-throughput LC-MS/MS screen for GHRP in equine and human urine, featuring peptide derivatization for improved chromatography |
| Q38005672 | A molecular imaging primer: modalities, imaging agents, and applications |
| Q57376621 | A new t-PA releasing concept based on protein–protein displacement |
| Q34110775 | A novel peptide derived from human pancreatitis-associated protein inhibits inflammation in vivo and in vitro and blocks NF-kappa B signaling pathway |
| Q37845684 | Anticonvulsant neuropeptides as drug leads for neurological diseases |
| Q42111353 | Antimicrobial activity of a halocidin-derived peptide resistant to attacks by proteases |
| Q50083695 | Antimicrobial peptides are degraded by the cytosolic proteases of human erythrocytes |
| Q27478055 | Antiviral Peptides Targeting the West Nile Virus Envelope Protein |
| Q93067924 | Application of Synthetic Molecular Evolution to the Discovery of Antimicrobial Peptides |
| Q42369377 | Backbone Modification of a Parathyroid Hormone Receptor-1 Antagonist/Inverse Agonist |
| Q38016605 | Bioactive oligopeptides in dermatology: Part I. |
| Q37143919 | Bioengineering approaches to controlled protein delivery |
| Q38120721 | Bioportides: bioactive cell-penetrating peptides that modulate cellular dynamics |
| Q27021529 | CNS active O-linked glycopeptides |
| Q37827163 | Carbohydrate-mimetic peptides: structural aspects of mimicry and therapeutic implications. |
| Q44719055 | Characterization and identification of a C-terminal amidated mechano growth factor (MGF) analogue in black market products. |
| Q48301259 | Characterization of in vitro generated metabolites of selected peptides <2 kDa prohibited in sports |
| Q48141739 | Chemical synthesis and orexigenic activity of rat/mouse relaxin-3. |
| Q40541284 | Chemically synthesized dicarba H2 relaxin analogues retain strong RXFP1 receptor activity but show an unexpected loss of in vitro serum stability |
| Q38703502 | Claudin peptidomimetics modulate tissue barriers for enhanced drug delivery. |
| Q36279390 | Coassembled cytotoxic and pegylated peptide amphiphiles form filamentous nanostructures with potent antitumor activity in models of breast cancer |
| Q40059658 | Combination therapy of an anticancer drug with the FNIII14 peptide of fibronectin effectively overcomes cell adhesion-mediated drug resistance of acute myelogenous leukemia |
| Q64068757 | Comparing sequence and structure of falcipains and human homologs at prodomain and catalytic active site for malarial peptide based inhibitor design |
| Q33884461 | Comparison of biological stability and metabolism of CCK2 receptor targeting peptides, a collaborative project under COST BM0607. |
| Q35260240 | Computational survey of peptides derived from disulphide-bonded protein loops that may serve as mediators of protein-protein interactions |
| Q44910150 | Conjugation of Paclitaxel to Hybrid Peptide Carrier and Biological Evaluation in Jurkat and A549 Cancer Cell Lines |
| Q96954310 | Current status and future directions of high-throughput ADME screening in drug discovery |
| Q38455317 | D-amino acid based protein arginine deiminase inhibitors: Synthesis, pharmacokinetics, and in cellulo efficacy |
| Q41466298 | DNA-Catalyzed Introduction of Azide at Tyrosine for Peptide Modification. |
| Q36544864 | De novo design of a tumor-penetrating peptide |
| Q90396850 | Design and Characterizations of Inhalable Poly(lactic-co-glycolic acid) Microspheres Prepared by the Fine Droplet Drying Process for a Sustained Effect of Salmon Calcitonin |
| Q37856278 | Design and development of peptides and peptide mimetics as antagonists for therapeutic intervention |
| Q45346537 | Design of a novel antimicrobial peptide activated by virulent proteases |
| Q54470308 | Detection and quantification of dermorphin and selected analogs in equine urine. |
| Q34661050 | Detection, quantification, and identification of dermorphin in equine plasma and urine by LC-MS/MS for doping control |
| Q90598614 | Development of Novel 111-In-Labelled DOTA Urotensin II Analogues for Targeting the UT Receptor Overexpressed in Solid Tumours |
| Q49424827 | Development of a novel stability indicating RP-HPLC method for quantification of Connexin43 mimetic peptide and determination of its degradation kinetics in biological fluids |
| Q33757865 | Differential stability of therapeutic peptides with different proteolytic cleavage sites in blood, plasma and serum |
| Q33686825 | Dimerization of a phage-display selected peptide for imaging of αvβ6- integrin: two approaches to the multivalent effect. |
| Q46196565 | Direct quantitative analysis of a 20 kDa PEGylated human calcitonin gene peptide antagonist in cynomolgus monkey serum using in-source CID and UPLC-MS/MS. |
| Q51768051 | Discovery of a competitive apelin receptor (APJ) antagonist. |
| Q58034989 | Disulfide Formation Strategies in Peptide Synthesis |
| Q37143137 | Drugging Membrane Protein Interactions |
| Q35097791 | Effects of polycaprolactone-based scaffolds on the blood-brain barrier and cerebral inflammation |
| Q40653699 | Enfuvirtide-PEG conjugate: A potent HIV fusion inhibitor with improved pharmacokinetic properties |
| Q38793040 | Erythrocyte-mediated delivery of recombinant enzymes. |
| Q38737096 | Evaluation of 68Ga-labeled iNGR peptide with tumor-penetrating motif for microPET imaging of CD13-positive tumor xenografts. |
| Q38220535 | Evaluation of genotoxicity testing of FDA approved large molecule therapeutics |
| Q38877441 | Evaluation of the Biological Properties and the Enzymatic Stability of Glycosylated Luteinizing Hormone-Releasing Hormone Analogs |
| Q45920202 | Formulation and evaluation of gemcitabine-loaded solid lipid nanoparticles. |
| Q26801319 | Fusion Proteins for Half-Life Extension of Biologics as a Strategy to Make Biobetters |
| Q26820824 | Future of coagulation factor replacement therapy |
| Q36457208 | High Proteolytic Resistance of Spider-Derived Inhibitor Cystine Knots |
| Q57657992 | Identification of Novel Cytotoxic Peptide KENPVLSLVNGMF from Marine Sponge Xestospongia testudinaria, with Characterization of Stability in Human Serum |
| Q36719729 | Identification of a complement receptor 1 peptide for inhibition of immune hemolysis |
| Q97588200 | Identification of a suitable peptidic molecular platform for the development of NPY(Y1)R-specific imaging agents |
| Q52874069 | Impact of fluorination on proteolytic stability of peptides: a case study with α-chymotrypsin and pepsin. |
| Q59807077 | Improved Biodistribution and Extended Serum Half-Life of a Bacteriophage Endolysin by Albumin Binding Domain Fusion |
| Q52578359 | Improving the Activity of Trp-Rich Antimicrobial Peptides by Arg/Lys Substitutions and Changing the Length of Cationic Residues. |
| Q47893467 | In vitro and in vivo characterization of designed immunogens derived from the CD-helix of the stem of influenza hemagglutinin |
| Q28543699 | In vitro metabolic stability of exendin-4: pharmacokinetics and identification of cleavage products |
| Q40672864 | Influence of multivalent nitrilotriacetic acid lipid-ligand affinity on the circulation half-life in mice of a liposome-attached His6-protein |
| Q54482424 | Inhibition of ocular neovascularization by a novel peptide derived from human placenta growth factor-1. |
| Q37609648 | Inhibitory effect of a novel peptide, H-RN, on keratitis induced by LPS or poly(I:C) in vitro and in vivo via suppressing NF-κB and MAPK activation |
| Q38563691 | Insights into the molecular mechanisms of action of bioportides: a strategy to target protein-protein interactions |
| Q28272997 | Introducing antigen-binding sites in structural loops of immunoglobulin constant domains: Fc fragments with engineered HER2/neu-binding sites and antibody properties |
| Q27671423 | Introducing lasso peptides as molecular scaffolds for drug design: engineering of an integrin antagonist |
| Q38956084 | Latest Advances Towards Ras Inhibition: A Medicinal Chemistry Perspective. |
| Q33559031 | Long-lasting enfuvirtide carrier pentasaccharide conjugates with potent anti-human immunodeficiency virus type 1 activity |
| Q30383551 | Mechanistic and quantitative insight into cell surface targeted molecular imaging agent design. |
| Q91581164 | Mechanistic insights into the pH-dependent membrane peptide ATRAM |
| Q64074549 | Metabolic resistance of the D-peptide RD2 developed for direct elimination of amyloid-β oligomers |
| Q50624935 | Metal-bound claMP Tag inhibits proteolytic cleavage. |
| Q37340299 | Mimicry of high-density lipoprotein: functional peptide-lipid nanoparticles based on multivalent peptide constructs |
| Q57840920 | Model foldamers: applications and structures of stable macrocyclic peptides identified using in vitro selection |
| Q41063994 | Modifications of a Nanomolar Cyclic Peptide Antagonist for the EphA4 Receptor To Achieve High Plasma Stability |
| Q57757444 | Multimerization results in formation of re-bindable metabolites: A proof of concept study with FSC-based minigastrin imaging probes targeting CCK2R expression |
| Q35041214 | N-alkylated aminoacyl sulfamoyladenosines as potential inhibitors of aminoacylation reactions and microcin C analogues containing D-amino acids |
| Q35627471 | NMEGylation: a novel modification to enhance the bioavailability of therapeutic peptides |
| Q38124859 | Nanotechnology for CNS delivery of bio-therapeutic agents |
| Q37362688 | Necrosis-inducing peptide has the beneficial effect on killing tumor cells through neuropilin (NRP-1) targeting |
| Q38104757 | New modalities in conformationally constrained peptides for potency, selectivity and cell permeation |
| Q37856312 | Non-invasive iontophoretic delivery of peptides and proteins across the skin. |
| Q64061136 | Novel Mannitol-Based Small Molecules for Inhibiting Aggregation of α-Synuclein Amyloids in Parkinson's Disease |
| Q53589920 | Novel anti-melanogenic hexapeptoids, PAL-10 and PAL-12. |
| Q44571005 | Novel integrin-targeted binding-triggered drug delivery system for methotrexate |
| Q40268569 | Nuclear medicine imaging and therapy of neuroendocrine tumours |
| Q28079063 | Oral Delivery of Protein Drugs Bioencapsulated in Plant Cells |
| Q36640081 | Oral delivery of human biopharmaceuticals, autoantigens and vaccine antigens bioencapsulated in plant cells |
| Q38909525 | PACE4 inhibitors and their peptidomimetic analogs block prostate cancer tumor progression through quiescence induction, increased apoptosis and impaired neovascularisation |
| Q65002586 | PEG-Poly(1-Methyl-l-Tryptophan)-Based Polymeric Micelles as Enzymatically Activated Inhibitors of Indoleamine 2,3-Dioxygenase. |
| Q28741459 | PEGylation potentiates the effectiveness of an antagonistic peptide that targets the EphB4 receptor with nanomolar affinity |
| Q35874451 | PEPstrMOD: structure prediction of peptides containing natural, non-natural and modified residues |
| Q36488030 | Peptide Backbone Composition and Protease Susceptibility: Impact of Modification Type, Position, and Tandem Substitution |
| Q39106145 | Peptide hormones and lipopeptides: from self-assembly to therapeutic applications. |
| Q35601619 | Peptide internalization enabled by folding: triple helical cell-penetrating peptides |
| Q36033291 | Peptides and Peptide Analogs to Inhibit Protein-Protein Interactions |
| Q33842909 | Peptides derived from MARCKS block coagulation complex assembly on phosphatidylserine. |
| Q38110433 | Pharmacokinetics and pharmacokinetic-pharmacodynamic correlations of therapeutic peptides. |
| Q28067866 | Polymer therapeutics in surgery: the next frontier |
| Q89433563 | Potential of Protein-based Anti-metastatic Therapy with Serpins and Inter α-Trypsin Inhibitors |
| Q39512185 | Preclinical evaluation of radiolabeled DOTA-derivatized cyclic minigastrin analogs for targeting cholecystokinin receptor expressing malignancies. |
| Q101137934 | Preparation, Characterization and Pharmacokinetic study of N-Terminal PEGylated D-form Antimicrobial Peptide OM19r-8 |
| Q33912692 | Protease-resistant peptide ligands from a knottin scaffold library |
| Q36795884 | Qualitative identification of growth hormone-releasing hormones in human plasma by means of immunoaffinity purification and LC-HRMS/MS. |
| Q40935440 | Rapid Screening of Antimicrobial Synthetic Peptides |
| Q92012955 | Rational Drug Design of Peptide-Based Therapies for Sickle Cell Disease |
| Q52391083 | Recent Advances in the Synthesis of Peptoid Macrocycles. |
| Q50865530 | Recent Innovations in Peptide Based Targeted Drug Delivery to Cancer Cells. |
| Q38659907 | Recombinant and chemo-/bio-orthogonal synthesis of liposomal thrombomodulin and its antithrombotic activity |
| Q99628392 | Research Progress of Radiolabeled Asn-Gly-Arg (NGR) Peptides for Imaging and Therapy |
| Q64115635 | Sea snake cathelicidin (Hc-cath) exerts a protective effect in mouse models of lung inflammation and infection |
| Q34273423 | Selection of peptide inhibitor to matrix metalloproteinase-2 using phage display and its effects on pancreatic cancer cell lines PANC-1 and CFPAC-1. |
| Q60917922 | Software-aided workflow for predicting protease-specific cleavage sites using physicochemical properties of the natural and unnatural amino acids in peptide-based drug discovery |
| Q30647857 | Solution phase conformation and proteolytic stability of amide-linked neuraminic acid analogues |
| Q52882489 | Stabilization of peptides for intracellular applications by phosphoramidate-linked polyethylene glycol chains. |
| Q38264736 | Strategic approaches to optimizing peptide ADME properties |
| Q36093836 | Structure-activity relationships and action mechanisms of collagen-like antimicrobial peptides. |
| Q43454656 | Structure-activity study of macropin, a novel antimicrobial peptide from the venom of solitary bee Macropis fulvipes (Hymenoptera: Melittidae). |
| Q34244234 | Structure-based mutagenesis reveals the albumin-binding site of the neonatal Fc receptor |
| Q99604665 | Synergies with and Resistance to Membrane-Active Peptides |
| Q86496123 | Synthesis of boron-containing primary amines |
| Q33852418 | Synthesis of chemically modified bioactive peptides: recent advances, challenges and developments for medicinal chemistry. |
| Q35050690 | Synthetic covalently linked dimeric form of H2 relaxin retains native RXFP1 activity and has improved in vitro serum stability. |
| Q56897486 | Targeted delivery of thrombolytic agents: role of integrin receptors |
| Q90383538 | The Effects of Fibrin-icariin Nanoparticle Loaded in Poly (lactic-co-glycolic) Acid Scaffold as a Localized Delivery System on Chondrogenesis of Human Adipose-derived Stem Cells |
| Q46286556 | The Exonization and Functionalization of an Alu-J Element in the Protein Coding Region of Glycoprotein Hormone Alpha Gene Represent a Novel Mechanism to the Evolution of Hemochorial Placentation in Primates |
| Q64109965 | The In Vitro Biotransformation of the Fusion Protein Tetranectin-Apolipoprotein A1 |
| Q39040413 | The designer leptin antagonist peptide Allo-aca compensates for short serum half-life with very tight binding to the receptor |
| Q48134745 | The detection of a synthetic Interleukin-1 receptor antagonist peptide in a seized product from a racing stable |
| Q38051263 | The enhanced permeability retention effect: a new paradigm for drug targeting in infection. |
| Q38175428 | The logic of metabolism and its fuzzy consequences |
| Q35857076 | The remarkable stability of chimeric, sialic acid-derived alpha/delta-peptides in human blood plasma |
| Q49188630 | Therapeutic Targeting of the Staphylococcus aureus Accessory Gene Regulator (agr) System |
| Q48089546 | Thrombin-Inhibiting Anticoagulant Liposomes: Development and Characterization. |
| Q34976054 | Tumor-penetrating peptides |
| Q47624521 | Utilizing Inverse Emulsion Polymerization To Generate Responsive Nanogels for Cytosolic Protein Delivery |
| Q24614628 | Vaccination with a synthetic peptide from the influenza virus hemagglutinin provides protection against distinct viral subtypes |
| Q37937049 | Venoms as a platform for human drugs: translating toxins into therapeutics |
| Q26752431 | Widening and Elaboration of Consecutive Research into Therapeutic Antioxidant Enzyme Derivatives |
Search more.